blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1935991

EP1935991 - Nucleic acid vaccines for prevention of flavivirus infection [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.09.2013
Database last updated on 23.04.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): LU		published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
The Government of the United States of America, as represented by the Secretary, Department of Health & Human Services
Technology Transfer Office, Centers for Disease Control and Prevention, 1600 Clifton Road, N.E., MS E-67
Atlanta, Georgia 30333 / US
[2008/26]
Inventor(s)01 / Chang, Gwong-Jen J.
4237 Beaver Creek Drive
Fort Collins, CO 80522 / US
 [2008/26]
Representative(s)Walton, Seán Malcolm, et al
Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[N/P]
Former [2012/45]Walton, Seán Malcolm, et al
Mewburn Ellis LLP 33 Gutter Lane London
EC2V 8AS / GB
Former [2008/26]Walton, Seán Malcolm, et al
Mewburn Ellis LLP York House 23 Kingsway
London WC2B 6HP / GB
Application number, filing date08004141.104.04.2002
[2008/26]
Priority number, dateUS2001082611504.04.2001         Original published format: US 826115
[2008/26]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1935991
Date:25.06.2008
Language:EN
[2008/26]
Type: A3 Search report 
No.:EP1935991
Date:10.09.2008
[2008/37]
Type: B1 Patent specification 
No.:EP1935991
Date:07.11.2012
Language:EN
[2012/45]
Search report(s)(Supplementary) European search report - dispatched on:EP11.08.2008
ClassificationIPC:C12Q1/70, G01N33/53, C12P21/06, C07K16/00, C07H21/04, A61K39/12, C07K14/18, C07K16/10, G01N33/569
[2008/26]
CPC:
C07K14/005 (EP,US); C12N15/11 (KR); A61K39/12 (EP,US);
A61P31/12 (EP); A61P31/14 (EP); A61P37/04 (EP);
C07K16/1081 (EP,US); C12Q1/701 (EP,US); G01N33/56983 (EP,US);
A61K2039/53 (EP,US); A61K2039/70 (EP,US); A61K48/00 (EP,US);
C07K2319/02 (EP,US); C12N2770/24022 (EP,US); C12N2770/24122 (EP,US);
C12N2770/24134 (EP,US); G01N2333/18 (EP,US); Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2008/26]
TitleGerman:Nukleinsäure-Impfstoffe zur Vorbeugung gegen Flavivirusinfektionen[2008/26]
English:Nucleic acid vaccines for prevention of flavivirus infection[2008/26]
French:Vaccins d'acide nucléique pour la prévention d'infection du flavivirus[2008/26]
Examination procedure14.03.2008Examination requested  [2008/26]
18.03.2009Despatch of a communication from the examining division (Time limit: M04)
12.06.2009Reply to a communication from the examining division
05.02.2010Despatch of a communication from the examining division (Time limit: M04)
02.06.2010Reply to a communication from the examining division
12.12.2011Despatch of a communication from the examining division (Time limit: M04)
14.03.2012Reply to a communication from the examining division
05.06.2012Communication of intention to grant the patent
05.09.2012Fee for grant paid
05.09.2012Fee for publishing/printing paid
Parent application(s)   TooltipEP02763960.8  / EP1383931
Divisional application(s)EP10177282.0  / EP2332572
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20020763960) is  02.09.2005
Opposition(s)08.08.2013No opposition filed within time limit [2013/42]
Fees paidRenewal fee
14.03.2008Renewal fee patent year 03
14.03.2008Renewal fee patent year 04
14.03.2008Renewal fee patent year 05
14.03.2008Renewal fee patent year 06
14.03.2008Renewal fee patent year 07
16.04.2009Renewal fee patent year 08
25.03.2010Renewal fee patent year 09
12.04.2011Renewal fee patent year 10
28.03.2012Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT07.11.2012
BE07.11.2012
CY07.11.2012
DK07.11.2012
FI07.11.2012
IT07.11.2012
MC07.11.2012
NL07.11.2012
SE07.11.2012
TR07.11.2012
GR08.02.2013
ES18.02.2013
PT07.03.2013
LU04.04.2013
CH30.04.2013
LI30.04.2013
[2015/34]
Former [2015/32]AT07.11.2012
BE07.11.2012
CY07.11.2012
DK07.11.2012
FI07.11.2012
IT07.11.2012
MC07.11.2012
NL07.11.2012
SE07.11.2012
TR07.11.2012
GR08.02.2013
ES18.02.2013
PT07.03.2013
CH30.04.2013
LI30.04.2013
Former [2014/08]AT07.11.2012
BE07.11.2012
CY07.11.2012
DK07.11.2012
FI07.11.2012
IT07.11.2012
MC07.11.2012
NL07.11.2012
SE07.11.2012
GR08.02.2013
ES18.02.2013
PT07.03.2013
CH30.04.2013
LI30.04.2013
Former [2014/01]AT07.11.2012
BE07.11.2012
CY07.11.2012
DK07.11.2012
FI07.11.2012
IT07.11.2012
MC07.11.2012
NL07.11.2012
SE07.11.2012
GR08.02.2013
ES18.02.2013
PT07.03.2013
Former [2013/37]AT07.11.2012
BE07.11.2012
CY07.11.2012
DK07.11.2012
FI07.11.2012
IT07.11.2012
NL07.11.2012
SE07.11.2012
GR08.02.2013
ES18.02.2013
PT07.03.2013
Former [2013/34]AT07.11.2012
BE07.11.2012
CY07.11.2012
DK07.11.2012
FI07.11.2012
NL07.11.2012
SE07.11.2012
GR08.02.2013
ES18.02.2013
PT07.03.2013
Former [2013/31]AT07.11.2012
BE07.11.2012
CY07.11.2012
FI07.11.2012
NL07.11.2012
SE07.11.2012
GR08.02.2013
ES18.02.2013
PT07.03.2013
Former [2013/28]BE07.11.2012
CY07.11.2012
FI07.11.2012
NL07.11.2012
SE07.11.2012
GR08.02.2013
ES18.02.2013
PT07.03.2013
Former [2013/27]BE07.11.2012
CY07.11.2012
FI07.11.2012
NL07.11.2012
SE07.11.2012
GR08.02.2013
ES18.02.2013
Former [2013/24]CY07.11.2012
FI07.11.2012
NL07.11.2012
SE07.11.2012
GR08.02.2013
ES18.02.2013
Former [2013/23]CY07.11.2012
FI07.11.2012
NL07.11.2012
SE07.11.2012
ES18.02.2013
Former [2013/22]FI07.11.2012
NL07.11.2012
SE07.11.2012
ES18.02.2013
Former [2013/21]SE07.11.2012
Documents cited:Search[DY]WO9306214  (US HEALTH [US]) [DY] 1-22 * the whole document *;
 [Y]WO9837911  (ORAVAX INC [US], et al) [Y] 1-22 * the whole document *;
 [A]WO9963095  (US GOV HEALTH & HUMAN SERV [US], et al) [A] 1-22 * the whole document *;
 [Y]  - PLETNEV A G ET AL, "CONSTRUCTION AND CHARACTERIZATION OF CHIMERIC TICK-BORNE ENCEPHALITIS/DENGUE TYPE 4 VIRUSES", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, (19921101), vol. 89, no. 21, ISSN 0027-8424, pages 10532 - 10536, XP002073935 [Y] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.89.21.10532
 [Y]  - CHANG GWONG-JEN J ET AL, "A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice", JOURNAL OF VIROLOGY, (200005), vol. 74, no. 9, ISSN 0022-538X, pages 4244 - 4252, XP002301741 [Y] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1128/JVI.74.9.4244-4252.2000
 [A]  - ARROYO J ET AL, "Molecular basis for attenuation of neurovirulence of a yellow fever virus/Japanese encephalitis virus chimera vaccine (chimerivax-je)", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (200101), vol. 75, no. 2, ISSN 0022-538X, pages 934 - 942, XP002967301 [A] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1128/JVI.75.2.934-942.2001
 [A]  - GUIRAKHOO F ET AL, "Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (200006), vol. 74, no. 12, ISSN 0022-538X, pages 5477 - 5485, XP002165591 [A] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1128/JVI.74.12.5477-5485.2000
 [A]  - KOCHEL T ET AL, "Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (19970405), vol. 15, no. 5, ISSN 0264-410X, pages 547 - 552, XP004059894 [A] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0264-410X(97)00215-6
 [A]  - PHILLPOTTS R J ET AL, "Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus", ARCHIVES OF VIROLOGY, NEW YORK, NY, US, (1996), vol. 141, no. 3/4, ISSN 0304-8608, pages 743 - 749, XP002119031 [A] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1007/BF01718332
 [A]  - KONISHI E ET AL, "Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (199806), vol. 72, no. 6, ISSN 0022-538X, pages 4925 - 4930, XP002119029 [A] 1-22 * the whole document *
 [A]  - LIN Y L (REPRINT) ET AL, "DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (199801), vol. 72, no. 1, ISSN 0022-538X, pages 191 - 200, XP002119030 [A] 1-22 * the whole document *
 [PX]  - CHANG G-J J ET AL, "FLAVIVIRUS DNA VACCINES CURRENT STATUS AND POTENTIAL", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, NEW YORK ACADEMY OF SCIENCES, NEW YORK, NY, US, (200112), vol. 951, ISSN 0077-8923, pages 272 - 285, XP009033267 [PX] 1-22 * the whole document *
 [PX]  - DAVIS B S ET AL, "West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (200105), vol. 75, no. 9, ISSN 0022-538X, pages 4040 - 4047, XP002239873 [PX] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1128/JVI.75.9.4040-4047.2001
 [T]  - CHANG GWONG-JEN J ET AL, "Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus.", VIROLOGY, (20030201), vol. 306, no. 1, ISSN 0042-6822, pages 170 - 180, XP002301742

DOI:   http://dx.doi.org/10.1016/S0042-6822(02)00028-4
by applicantUS3610795
 US4810492
 US5021347
 WO9306214
 US5229293
 US5494671
 US5514375
 US5545806
 US5569825
 US5625126
    - KUNO ET AL., J. VIROL., (1998), vol. 72, pages 73 - 83
    - MONATH, Virology, RAVEN PRESS, (1990), pages 763 - 814
    - HEINZ; ROEHRIG, Immunochemistry of Viruses II: The Basis for Serodiagnosis and Vaccines, ELSEVIER, (1990), pages 289 - 305
    - SUMIYOSHI, VIROLOGY, (1987), vol. 161, pages 497 - 510
    - HASHIMOTO ET AL., VIRUS GENES, (1988), vol. 1, pages 305 - 317
    - NITAYAPHAN ET AL., VIROLOGY, (1990), vol. 177, pages 541 - 552
    - DEUBEL ET AL., VIROLOGY, (1986), vol. 155, pages 365 - 377
    - GRUENBERG ET AL., J. GEN. VIROL., (1988), vol. 69, pages 1391 - 1398
    - HAHN ET AL., VIROLOGY, (1988), vol. 162, pages 167 - 180
    - OSATOMI ET AL., VIRUS GENES, (1988), vol. 2, pages 99 - 108
    - MACKOW ET AL., VIROLOGY, (1987), vol. 159, pages 217 - 228
    - ZHAO ET AL., VIROLOGY, (1986), vol. 155, pages 77 - 88
    - LANCIOTTI ET AL., SCIENCE, (1999), vol. 286, pages 2331 - 2333
    - MANDL ET AL., VIROLOGY, (1993), vol. 194, pages 173 - 184
    - RICE ET AL., SCIENCE, (1985), vol. 229, pages 726 - 733
    - SMITHBURN ET AL., AM. J. TROP. MED. HYG., (1940), vol. 20, pages 471 - 492
    - HUBALEK ET AL., EMERG. INFECT. DIS., (1999), vol. 5, pages 643 - 50
    - MONATH; TSAI, Clinical Virology, (1997), pages 1133 - 1186
    - ASNIS ET AL., CLIN. INFECT. DIS., (2000), vol. 30, pages 413 - 418
    - ANDERSON ET AL., SCIENCE, (1999), vol. 286, pages 2331 - 2333
    - JIA ET AL., LANCET, (1999), vol. 354, pages 1971 - 1972
    - LANCIOTTI ET AL., SCIENCE, (1999), vol. 286, pages 2333 - 2337
    - MORB. MORTAL. WKLY. REP., (2000), vol. 49, pages 178 - 179
    - GARMENDIA ET AL., J. CLIN. MICRO., (2000), vol. 38, pages 3110 - 3111
    - MORB. MORTAL. WKLY. REP., (2000), vol. 49, pages 820 - 822
    - TSAI ET AL., Vaccines, (1999), pages 672 - 710
    - TSAI ET AL., VACCINES, (1994), pages 671 - 713
    - CAB INTERNATIONAL, (1997), pages 23 - 44
    - KONISHI ET AL., VIROLOGY, (1991), vol. 180, no. 10, pages 401 - 4
    - KONISHI ET AL., VIROLOGY, (1992), vol. 188, pages 714 - 720
    - DMITRIEV ET AL., J. BIOTECHNOLOGY, (1996), vol. 44, pages 97 - 103
    - ZHAO ET AL., J. VIROL., (1987), vol. 61, pages 4019 - 4022
    - ZHANG, J. VIROL., (1988), vol. 62, pages 3027 - 3031
    - BRAY ET AL., J. VIROL., (1989), vol. 63, pages 2853 - 2856
    - FALGOUT ET AL., J. VIROL, (1989), vol. 63, pages 1852 - 1860
    - FALGOUT ET AL., J. VIROL., (1990), vol. 64, pages 4356 - 4363
    - ZHANG ET AL., J. VIROL, (1988), vol. 62, pages 3027 - 3031
    - LAI ET AL., Vaccines, COLD SPRING HARBOR LABORATORY, (1990), vol. 90, pages 119 - 124
    - PHILLPOTTS ET AL., ARCH. VIROL., (1996), vol. 141, pages 743 - 749
    - KOCHEL ET AL., VACCINE, (1997), vol. 15, pages 547 - 552
    - PHILJPOTTS ET AL., ARCH. VIROL., (1996), vol. 141, pages 743 - 749
    - HENNESSY ET AL., LANCET, (1996), vol. 347, pages 1583 - 1586
    - KOZAK, MOL. CELL. BIOLOGY, (1989), vol. 9, pages 5134 - 5142
    - SATO ET AL., SCIENCE, (1996), vol. 273, pages 352 - 354
    - KLINMAN, VACCINE, (1998), vol. 17, pages 19 - 25
    - KUNO, J. VIROL., (1998), vol. 72, pages 73 - 83
    - AZEVEDO ET AL., BRAZ. J. MED. BIOL. RES., (1999), vol. 32, pages 147 - 153
    - Synthetic Vaccines, CRC PRESS, (1987), pages 83 - 92
    - MIR ET AL., PROC. NAT. ACAD. SCI USA, (1999), vol. 96, pages 4262 - 4267
    - KOHLER ET AL., NATURE, (1975), vol. 256, pages 495 - 97
    - ALVAREZ ET AL., HUM. GENE THER., (1997), vol. 8, pages 229 - 242
    - YANG ET AL., NATURE, (1996), vol. 382, pages 319 - 324
    - KIMURA-KURODA ET AL., J. VIROL., (1983), vol. 45, pages 124 - 132
    - KIMURA-KURODA ET AL., J. GEN. VIROL., (1986), vol. 67, pages 2663 - 2672
    - ZHANG ET AL., J. MED. VIROL., (1989), vol. 29, pages 133 - 138
    - ROEHRIG ET AL., VIROL., (1983), vol. 128, pages 118 - 126
    - LAEMMLI, NATURE, (1970), vol. 277, pages 680 - 685
    - HENCHAL ET AL., AMER. J. TROP. MED. HYG., (1982), vol. 31, pages 830 - 836
    - KONISHI ET AL., VIROL., (1992), vol. 188, pages 714 - 720
    - CLARKE; CASALS, AMER. J. TROP. MED. HYG., (1958), vol. 7, pages 561 - 573
    - ROEHRIG ET AL., VIROL., (1989), vol. 171, pages 49 - 60
    - HUNT; CALISHER, AMER. J. TROP. MED. HYG., (1979), vol. 28, pages 740 - 749
    - CHANG ET AL., J. VIROL., (2000), vol. 74, pages 4244 - 4252
    - HENCHAL ET AL., AM. J. TROP. MED. HYG., (1982), vol. 31, pages 830 - 836
    - CHANG ET AL., J. VIROL., (2000), vol. 74, pages 4244 - 4452
    - HENCHAL ET AL., AM. J. TROP. MED. HYG., (1983), vol. 31, pages 830 - 836
    - ROEHRIG ET AL., VIROLOGY, (1983), vol. 128, pages 118 - 126
    - AIZAWA ET AL., APPL. ENVIRO. MICRO., (1980), vol. 39, pages 54 - 57
    - CLARKE ET AL., AM. J. TROP. MED. HYG., (1958), vol. 7, pages 561 - 573
    - JOHNSON ET AL., J. CLIN. MICROBIOL., (2000), vol. 38, pages 1827 - 1831
    - MARTIN ET AL., J. CLIN. MICROBIOL., (2000), vol. 38, pages 1823 - 1826
    - TARDEI ET AL., J. CLIN. MICROBIOL., (1940), vol. 38, pages 2232 - 2239
    - MIR ET AL., PROC. NATL. ACAD. SCI. USA, (1999), vol. 96, pages 4262 - 4267
    - MIR ET AL., PROC. NATL. ACAD. SCI. USA., (1999), vol. 96, pages 4262 - 4267
    - TRENT ET AL., VIROLOGY, (1987), vol. 156, pages 293 - 304
    - SANTOS ET AL., VIRUS RESEARCH, (1995), vol. 35, pages 35 - 41
    - GRUENBERG ET AL., J. GEN. VIROL., (1988), vol. 69, pages 1301 - 1398
    - VON HEIJNE, "Signal sequences. The limits of variation", J. MOL. BIOL., (1985), vol. 184, pages 99 - 105
    - LOBIGS, "Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3", PROC. NATL. ACAD. SCI. U S A., (1993), vol. 90, pages 6218 - 6222
    - "Prediction of signal peptides and signal anchors by a hidden Markov model", HENRIK NIELSEN ET AL., Proceedings of the Sixth International Conference on Intelligent Systems for Molecular Biology (ISMB 6, AAAI PRESS, (1998), pages 122 - 130
    - NIELSEN ET AL., "Machine learning approaches to the prediction of signal peptides and other protein sorting signals", PROTEIN ENGINEERING, (1999), vol. 12, pages 3 - 9
    - NIELSEN ET AL., "A neural network method for identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites", INT. J. NEURAL SYS., (1997), vol. 8, pages 581 - 599
    - CHANG ET AL., "Flavivirus DNA vaccines: current status and potential", ANNALS OF NYACAD. SCI., (2001), vol. 951, pages 272 - 285
    - SAKAGUCHI ET AL., "Functions of Signal and Signal-Anchor Sequences are Determined by the Balance Between the Hydrophobic Segment and the N-Terminal Charge", PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 16 - 19
    - LIN ET AL., "DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice", J. VIROL., (1998), vol. 72, pages 191 - 200
    - KONISHI ET AL., "Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes", J. VIROL., (1998), vol. 72, pages 4925 - 4930
    - CHANG ET AL., "A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice", J. VIROL., (2000), vol. 74, pages 4244 - 4252
    - DAVIS ET AL., "West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays", J. VIROL., (2001), vol. 75, pages 4040 - 4047
    - GUILLOT ET AL., "Natural Genetic Exchanges between Vaccine and Wild Poliovirus Strains in Humans", J. VIROL., (2000), vol. 74, pages 8434 - 8443
    - LIU ET AL., "Molecular Evolution of a Type 1 Wild-Vaccine Poliovirus Recombinant during Widespread Circulation in China", J. VIROL., (2000), vol. 74, pages 11153 - 11161
    - CHANG ET AL., "Nucleotide sequence variation of the envelope protein gene identifies two distinct genotypes of yellow fever virus", J. VIROL., (1995), vol. 69, pages 5773 - 5780
    - PISANO ET AL., "Complete nucleotide sequence and phylogeny of an American strain of yellow fever virus, TRINID79A", ARCH. VIROL., (1999), vol. 144, pages 1837 - 1843
    - CHANG ET AL., "Flavivirus DNA vaccines: current status and potential", ANN. NYACAD. SCI., (2001), vol. 951, pages 272 - 285
    - OBIJESKI ET AL., "Segmented genome and nucleocapsid of La Crosse virus", J. VIROL., (1976), vol. 20, pages 664 - 675
    - GADKARI ET AL., "Critical evaluation of Kyasanur Forest disease virus neutralizing antibodies found in bats (a preliminary report", INDIAN J. MED. RES., (1976), vol. 64, pages 64 - 67
    - KINNEY ET AL., "Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53", VIROLOGY, (1997), vol. 230, pages 300 - 308
    - HUNT ET AL., "A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen", J. VIROL. METHODS., (2001), vol. 97, pages 133 - 149
    - MURRAY ET AL., "Processing of the dengue virus type 2 proteins prM and C-prM", J. GEN. VIROL., (1993), vol. 74, no. 2, pages 175 - 182
    - ROEHRIG ET AL., "Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica", VIROLOGY, (1998), vol. 246, pages 317 - 328
    - HENCHAL ET AL., "Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies", AM. J. TROP. MED. HYG., (1985), vol. 34, pages 162 - 169
    - MANDL ET AL., "Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model", J. VIROL., (1989), vol. 63, pages 564 - 571
    - REY ET AL., "The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution", NATURE, (1995), vol. 375, pages 291 - 298
    - ALLISON ET AL., "Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E", J. VIROL., (1999), vol. 73, pages 5605 - 5612
    - ABERLE ET AL., "A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms", J. IMMUNOL., (1999), vol. 163, pages 6756 - 6761
    - ALLISON ET AL., "Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form", J. VIROL., (1995), vol. 69, pages 5816 - 5820
    - GUIRAKHOO ET AL., "The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein", VIROLOGY, (1992), vol. 191, pages 921 - 931
    - KOCHEL ET AL., "Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice", VACCINE, (1997), vol. 15, pages 547 - 552
    - KONISHI ET AL., "A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice", VACCINE, (2000), vol. 18, pages 1133 - 1139
    - PORTER ET AL., "Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses", ARCH. VIROL., (1998), vol. 143, pages 997 - 1003
    - RAVIPRAKASH ET AL., "Synergistic Neutralizing Antibody Response to a Dengue Virus Type 2 DNA Vaccine by Incorporation of Lysosome-Associated Membrane Protein Sequences and Use of Plasmid Expressing GM-CSF", VIROLOGY, (2001), vol. 290, pages 74 - 82
    - MANDERS ET AL., "Immunology of DNA vaccines: CpG motifs and antigen presentation", INFLAMM. RES., (2000), vol. 49, pages 199 - 205
    - SMITH ET AL., "The regulation of DNA vaccines", CURR. OPIN. BIOTECH., (2001), vol. 12, pages 299 - 303
    - ROBERTSON ET AL., "Assuring the quality, safety, and efficacy of DNA vaccines", MOL. BIOTECHNOL., (2001), vol. 17, pages 143 - 149
    - RODRIGUEZ ET AL., "Enhancing DNA immunization", VIROLOGY, (2000), vol. 268, pages 233 - 238
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.